CD36 (Platelet & Microvessel Marker)(1A7), CF640R conjugate, 0.1mg/mL [26628-22-8]
BNC400299
ApplicationsFunctional Assay, ImmunoPrecipitation, Western Blot
Product group Antibodies
ReactivityBovine, Human, Mouse
TargetCD36
Overview
- SupplierBiotium
- Product NameCD36 (Platelet & Microvessel Marker)(1A7), CF640R conjugate, 0.1mg/mL
- Delivery Days Customer9
- ApplicationsFunctional Assay, ImmunoPrecipitation, Western Blot
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID1A7
- Concentration0.1 mg/ml
- ConjugateOther Conjugate
- Gene ID948
- Target nameCD36
- Target descriptionCD36 molecule
- Target synonymsBDPLT10; CD36 antigen (collagen type I receptor, thrombospondin receptor); CD36 molecule (thrombospondin receptor); CHDS7; cluster determinant 36; FAT; fatty acid translocase; glycoprotein IIIb; GP3B; GP4; GPIIIB; GPIV; leukocyte differentiation antigen CD36; PAS IV; PAS-4 protein; PASIV; platelet glycoprotein 4; platelet glycoprotein IV; SCARB3; scavenger receptor class B, member 3
- HostMouse
- IsotypeIgG2b
- Protein IDP16671
- Protein NamePlatelet glycoprotein 4
- Scientific DescriptionThis antibody recognizes a protein of 80-90 kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36.
- SourceAnimal
- ReactivityBovine, Human, Mouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203